Description
Product details
TACOTINIB ER 11 Tofacitinib Extended Release 11 mg TACOTINIB 5: A Closer Look at Tofacitinib 5mg for Rheumatic Conditions TACOTINIB 5, containing 5mg of Tofacitinib, is an innovative medication designed for the treatment of various rheumatic conditions, including rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis. This article provides a comprehensive overview of TACOTINIB 5, discussing its mechanism, uses, benefits, dosage recommendations, potential side effects, and safety precautions. What is TACOTINIB 5? TACOTINIB 5 features Tofacitinib, a Janus kinase (JAK) inhibitor, which works by interfering with the enzyme pathway that leads to inflammation and immune response. By targeting these pathways, Tofacitinib helps to reduce inflammation, pain, and damage to affected joints or gastrointestinal regions in patients with autoimmune conditions. Uses and Benefits Therapeutic Applications: Rheumatoid Arthritis (RA): Tofacitinib is approved for the treatment of moderate to severe RA, helping to reduce symptoms, improve physical function, and slow the progression of joint damage. Psoriatic Arthritis: It is used in patients who have had an inadequate response to other therapies, reducing symptoms and preventing further joint deterioration. Ulcerative Colitis: Tofacitinib is also used for treating moderate to severe ulcerative colitis, reducing the frequency of flare-ups and promoting mucosal healing. Advantages: Symptom Reduction: Provides significant relief from joint pain, swelling, and stiffness associated with inflammatory arthritis. Improved Mobility: Helps improve the quality of life by enhancing physical function and mobility. Oral Administration: Unlike many traditional treatments that require injections, TACOTINIB 5 is available in an oral tablet form, making it convenient for daily use. Dosage and Administration The typical dosage of TACOTINIB 5 involves taking one tablet twice a day. It can be taken with or without food. However, the exact dosage and treatment regimen should be prescribed by a healthcare provider based on individual patient needs and medical conditions. Side Effects and Precautions Potential Side Effects: Common side effects include upper respiratory tract infections, headaches, diarrhea, and high blood pressure. Serious side effects can include increased risk of serious infections such as tuberculosis, bacterial, fungal, or viral infections. There may be an increased risk of blood clots, which can be severe and lead to death. Precautions: Infection Screening: Patients should be screened for tuberculosis and other infections before starting treatment with TACOTINIB 5. Monitoring: Regular monitoring of blood counts, lipid levels, and liver enzyme levels is recommended. Vaccinations: Live vaccines should generally be avoided during treatment with Tofacitinib. For further information: EMAIL: info@sterispharma.com / contact@sterispharma.com CALL/WHATSAPP: 7877551268, 7849827488 https://www.sterisonline.com/product/tacotinib-er-11-134085
